FDA Import Refusal 1FX-4781964-5/10002/1 — Cipla Limited
The FDA refused shipment 1FX-4781964-5/10002/1 from Cipla Limited (India) on Sep 30, 2026. The refused product falls under Drugs and Biologics — CLOPIDOGREL BISULFATE (ANTI-COAGULANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 30, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61LDA38 CLOPIDOGREL BISULFATE (ANTI-COAGULANT)
- Charges
- 75